Metraipolis › archive › dc_068aa0c69da2

Bortezomib combined with lenalidomide as the first-line treatment for the rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma: A case… — Europe PMC PMID:28072730

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/28072730
DOI
10.1097/md.0000000000005787
License (as archived)
solo-consultazione
Archived
2026-11-09T20:38:57.771Z
SHA-256 of the archived text
a5c7a2432ea973f14d4128786b308e7648ad4b15c7720931db6014b09097cc3a
Stable URL of this page
https://metraipolis.com/documento/dc_068aa0c69da2

How to cite

Bortezomib combined with lenalidomide as the first-line treatment for the rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma: A case… — Europe PMC PMID:28072730 — Europe PMC (en), https://europepmc.org/article/MED/28072730 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_068aa0c69da2 (Metraipolis archive dc_068aa0c69da2, sha256 a5c7a2432ea973f14d4128786b308e7648ad4b15c7720931db6014b09097cc3a)
BibTeX
@misc{dc068aa0c69da2,
  title = {Bortezomib combined with lenalidomide as the first-line treatment for the rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma: A case… — Europe PMC PMID:28072730},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/28072730},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_068aa0c69da2; sha256 a5c7a2432ea973f14d4128786b308e7648ad4b15c7720931db6014b09097cc3a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/28072730. Agents can read the archived copy with the MCP tool read_document.